BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohen SM, Lippard SJ. Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol. 2001;67:93-130. [PMID: 11525387 DOI: 10.1016/s0079-6603(01)67026-0] [Cited by in Crossref: 379] [Cited by in F6Publishing: 120] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Dupre TV, Doll MA, Shah PP, Sharp CN, Kiefer A, Scherzer MT, Saurabh K, Saforo D, Siow D, Casson L, Arteel GE, Jenson AB, Megyesi J, Schnellmann RG, Beverly LJ, Siskind LJ. Suramin protects from cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol 2016;310:F248-58. [PMID: 26661653 DOI: 10.1152/ajprenal.00433.2015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
2 Campbell MA, Miller PS. Phosphodiester-mediated reaction of cisplatin with guanine in oligodeoxyribonucleotides. Biochemistry 2008;47:12931-8. [PMID: 18991396 DOI: 10.1021/bi801000w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Zhu L, Zou J, Zhao Y, Jiang X, Wang Y, Wang X, Chen B. ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway. J Exp Clin Cancer Res 2018;37:123. [PMID: 29940998 DOI: 10.1186/s13046-018-0798-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
4 Mondal J, Patra M, Panigrahi AK, Khuda-Bukhsh AR. Improved drug carriage and protective potential against Cisplatin-induced toxicity using Boldine-loaded PLGA nanoparticles. J Ayurveda Integr Med 2020;11:24-36. [PMID: 30115410 DOI: 10.1016/j.jaim.2017.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Spreckelmeyer S, Orvig C, Casini A. Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin. Molecules. 2014;19:15584-15610. [PMID: 25268716 DOI: 10.3390/molecules191015584] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 15.4] [Reference Citation Analysis]
6 Novakova O, Kasparkova J, Malina J, Natile G, Brabec V. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes. Nucleic Acids Res 2003;31:6450-60. [PMID: 14602903 DOI: 10.1093/nar/gkg863] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 4.8] [Reference Citation Analysis]
7 Heringova P, Kasparkova J, Brabec V. DNA adducts of antitumor cisplatin preclude telomeric sequences from forming G quadruplexes. J Biol Inorg Chem 2009;14:959-68. [PMID: 19390878 DOI: 10.1007/s00775-009-0508-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
8 Yuan Z, Cao K, Lin C, Li L, Liu HY, Zhao XY, Liu L, Deng HX, Li J, Nie CL, Wei YQ. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1. Mol Med 2011;17:1262-74. [PMID: 21863213 DOI: 10.2119/molmed.2011.00176] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
9 Bottone MG, Soldani C, Veneroni P, Avella D, Pisu M, Bernocchi G. Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment. Cell Prolif 2008;41:506-20. [PMID: 18397337 DOI: 10.1111/j.1365-2184.2008.00530.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
10 Heo JI, Oh SJ, Kho YJ, Kim JH, Kang HJ, Park SH, Kim HS, Shin JY, Kim MJ, Kim M, Kim SC, Park JB, Kim J, Lee JY. ATM mediates interdependent activation of p53 and ERK through formation of a ternary complex with p-p53 and p-ERK in response to DNA damage. Mol Biol Rep 2012;39:8007-14. [PMID: 22576881 DOI: 10.1007/s11033-012-1647-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
11 Yu X, Meng X, Xu M, Zhang X, Zhang Y, Ding G, Huang S, Zhang A, Jia Z. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function. EBioMedicine 2018;36:266-80. [PMID: 30268831 DOI: 10.1016/j.ebiom.2018.09.031] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
12 Wappler J, Arts M, Röth A, Heeren RMA, Peter Neumann U, Olde Damink SW, Soons Z, Cramer T. Glutamine deprivation counteracts hypoxia-induced chemoresistance. Neoplasia 2020;22:22-32. [PMID: 31765939 DOI: 10.1016/j.neo.2019.10.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
13 Yin J, Wang J. Renal drug transporters and their significance in drug-drug interactions. Acta Pharm Sin B 2016;6:363-73. [PMID: 27709005 DOI: 10.1016/j.apsb.2016.07.013] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
14 Oh GS, Kim HJ, Shen A, Lee SB, Yang SH, Shim H, Cho EY, Kwon KB, Kwak TH, So HS. New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity. Biomed Res Int 2016;2016:4048390. [PMID: 26881219 DOI: 10.1155/2016/4048390] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
15 Zhang Y, Song Y, Li C, Ren J, Fang M, Fang J, Wang X. Brother of regulator of imprinted sites inhibits cisplatin-induced DNA damage in non-small cell lung cancer. Oncol Lett 2020;20:251. [PMID: 32994814 DOI: 10.3892/ol.2020.12114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Samuel P, Pink RC, Caley DP, Currie JM, Brooks SA, Carter DR. Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells. Tumour Biol 2016;37:2565-73. [PMID: 26386726 DOI: 10.1007/s13277-015-4081-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
17 Kohno K, Wang KY, Takahashi M, Kurita T, Yoshida Y, Hirakawa M, Harada Y, Kuma A, Izumi H, Matsumoto S. Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy. Int J Mol Sci 2015;16:19836-50. [PMID: 26307971 DOI: 10.3390/ijms160819836] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
18 Ma Y, Trump DL, Johnson CS. Vitamin D in combination cancer treatment. J Cancer. 2010;1:101-107. [PMID: 20842231 DOI: 10.7150/jca.1.101] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
19 Liu Y, Xing H, Han X, Shi X, Liang F, Cheng G, Lu Y, Ma D. Apoptosis of HeLa cells induced by cisplatin and its mechanism. J Huazhong Univ Sci Technolog Med Sci 2008;28:197-9. [PMID: 18480997 DOI: 10.1007/s11596-008-0221-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
20 Zhang R, Li Y, Dong X, Peng L, Nie X. MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer. Med Oncol. 2014;31:347. [PMID: 25416050 DOI: 10.1007/s12032-014-0347-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
21 Schott S, Wimberger P, Klink B, Grützmann K, Puppe J, Wauer US, Klotz DM, Schröck E, Kuhlmann JD. The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells in vitro. Oncotarget 2017;8:76935-48. [PMID: 29100359 DOI: 10.18632/oncotarget.20260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
22 Luo H, Yang A, Schulte BA, Wargovich MJ, Wang GY. Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. PLoS One. 2013;8:e60065. [PMID: 23533664 DOI: 10.1371/journal.pone.0060065] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 12.0] [Reference Citation Analysis]
23 Wang L, Zhang Y, Zhao J, Xiao E, Lu J, Fu S, Wang Z. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro. Tumour Biol 2014;35:10879-90. [PMID: 25085582 DOI: 10.1007/s13277-014-2353-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
24 Brodbelt JS. Photodissociation mass spectrometry: new tools for characterization of biological molecules. Chem Soc Rev 2014;43:2757-83. [PMID: 24481009 DOI: 10.1039/c3cs60444f] [Cited by in Crossref: 202] [Cited by in F6Publishing: 114] [Article Influence: 28.9] [Reference Citation Analysis]
25 Liu J, Yang L, Zhang J, Zhang J, Chen Y, Li K, Li Y, Li Y, Yao L, Guo G. Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression. BMC Cancer 2012;12:370. [PMID: 22920753 DOI: 10.1186/1471-2407-12-370] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
26 Huszno J, Budryk M, Kołosza Z, Nowara E. The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation. Contemp Oncol (Pozn) 2015;19:72-6. [PMID: 26199574 DOI: 10.5114/wo.2015.50014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
27 Kumar A, Moody L, Olaivar JF, Lewis NA, Khade RL, Holder AA, Zhang Y, Rangachari V. Inhibition of Aβ42 peptide aggregation by a binuclear ruthenium(II)-platinum(II) complex: Potential for multi-metal organometallics as anti-amyloid agents. ACS Chem Neurosci 2010;2010:691-701. [PMID: 21221412 DOI: 10.1021/cn100046m] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
28 Jensen R, Glazer PM. Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions. Proc Natl Acad Sci USA. 2004;101:6134-6139. [PMID: 15069205 DOI: 10.1073/pnas.0400051101] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
29 Li YL, Lin ML, He SQ, Jin JF. Sphingolipid metabolism affects the anticancer effect of cisplatin. World J Transl Med 2016; 5(1): 37-45 [DOI: 10.5528/wjtm.v5.i1.37] [Reference Citation Analysis]
30 Raji GR, Poyyakkara A, Krishnan AK, Maurya AK, Changmai U, Shankar SS, Kumar VBS. Horizontal Transfer of miR-643 from Cisplatin-Resistant Cells Confers Chemoresistance to Recipient Drug-Sensitive Cells by Targeting APOL6. Cells 2021;10:1341. [PMID: 34071504 DOI: 10.3390/cells10061341] [Reference Citation Analysis]
31 Bratasz A, Selvendiran K, Wasowicz T, Bobko A, Khramtsov VV, Ignarro LJ, Kuppusamy P. NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols. J Transl Med 2008;6:9. [PMID: 18302761 DOI: 10.1186/1479-5876-6-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
32 Mårtensson AK, Bergentall M, Tremaroli V, Lincoln P. Diastereomeric bactericidal effect of Ru(phenanthroline)2 dipyridophenazine. Chirality 2016;28:713-20. [PMID: 27791316 DOI: 10.1002/chir.22656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
33 Vijayalakshmi B, Sesikeran B, Udaykumar P, Kalyanasundaram S, Raghunath M. Chronic low vitamin intake potentiates cisplatin-induced intestinal epithelial cell apoptosis in WNIN rats. World J Gastroenterol 2006; 12(7): 1078-1085 [PMID: 16534849 DOI: 10.3748/wjg.v12.i7.1078] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
34 Gao Z, Liu G, Hu Z, Li X, Yang X, Jiang B, Li X. Grape seed proanthocyanidin extract protects from cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis. Mol Med Rep 2014;9:801-7. [PMID: 24399449 DOI: 10.3892/mmr.2014.1883] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
35 Lin SH, Li MH, Chuang KA, Lin NH, Chang CH, Wu HC, Chao YH, Lin CC, Pan IH, Perng MD, Wen SF. Chlorella sorokiniana Extract Prevents Cisplatin-Induced Myelotoxicity In Vitro and In Vivo. Oxid Med Cell Longev 2020;2020:7353618. [PMID: 32047579 DOI: 10.1155/2020/7353618] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Oh GS, Kim HJ, Choi JH, Shen A, Choe SK, Karna A, Lee SH, Jo HJ, Yang SH, Kwak TH, Lee CH, Park R, So HS. Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice. Kidney Int 2014;85:547-60. [PMID: 24025646 DOI: 10.1038/ki.2013.330] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 9.8] [Reference Citation Analysis]
37 Islam MK, Baek AR, Sung B, Yang BW, Choi G, Park HJ, Kim YH, Kim M, Ha S, Lee GH, Kim HK, Chang Y. Synthesis, Characterization, and Anticancer Activity of Benzothiazole Aniline Derivatives and Their Platinum (II) Complexes as New Chemotherapy Agents. Pharmaceuticals (Basel) 2021;14:832. [PMID: 34451928 DOI: 10.3390/ph14080832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Mukhopadhyay S, Barnés CM, Haskel A, Short SM, Barnes KR, Lippard SJ. Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature. Bioconjug Chem 2008;19:39-49. [PMID: 17845003 DOI: 10.1021/bc070031k] [Cited by in Crossref: 184] [Cited by in F6Publishing: 169] [Article Influence: 13.1] [Reference Citation Analysis]
39 Zhirov AM, Kovalev DA, Ulshina DV, Pisarenko SV, Demidov OP, Borovlev IV. Diazapyrenes: interaction with nucleic acids and biological activity. Chem Heterocycl Compd (N Y) 2020;:1-20. [PMID: 32836316 DOI: 10.1007/s10593-020-02717-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Arsenijevic M, Milovanovic M, Jovanovic S, Arsenijevic N, Markovic BS, Gazdic M, Volarevic V. In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells. J Biol Inorg Chem 2017;22:807-17. [PMID: 28421385 DOI: 10.1007/s00775-017-1459-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
41 Kozubík A, Vaculová A, Soucek K, Vondrácek J, Turánek J, Hofmanová J. Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism. Met Based Drugs 2008;2008:417897. [PMID: 18414587 DOI: 10.1155/2008/417897] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
42 Gutiérrez-Romero L, Rivas-García L, Sánchez-González C, Llopis J, Blanco E, Montes-Bayón M. Cellular Toxicity Mechanisms and the Role of Autophagy in Pt(IV) Prodrug-Loaded Ultrasmall Iron Oxide Nanoparticles Used for Enhanced Drug Delivery. Pharmaceutics 2021;13:1730. [PMID: 34684023 DOI: 10.3390/pharmaceutics13101730] [Reference Citation Analysis]
43 Ognjanović BI, Djordjević NZ, Matić MM, Obradović JM, Mladenović JM, Stajn AŠ, Saičić ZS. Lipid peroxidative damage on Cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium. Int J Mol Sci 2012;13:1790-803. [PMID: 22408424 DOI: 10.3390/ijms13021790] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 8.4] [Reference Citation Analysis]
44 Sharp CN, Siskind LJ. Developing better mouse models to study cisplatin-induced kidney injury. Am J Physiol Renal Physiol 2017;313:F835-41. [PMID: 28724610 DOI: 10.1152/ajprenal.00285.2017] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 11.5] [Reference Citation Analysis]
45 Huang CY, Ju DT, Chang CF, Muralidhar Reddy P, Velmurugan BK. A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. Biomedicine (Taipei). 2017;7:23. [PMID: 29130448 DOI: 10.1051/bmdcn/2017070423] [Cited by in Crossref: 150] [Cited by in F6Publishing: 131] [Article Influence: 37.5] [Reference Citation Analysis]
46 Malina J, Novakova O, Vojtiskova M, Natile G, Brabec V. Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog. Biophys J 2007;93:3950-62. [PMID: 17704160 DOI: 10.1529/biophysj.107.116996] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
47 Wang J, Pan W. The Biological Role of the Collagen Alpha-3 (VI) Chain and Its Cleaved C5 Domain Fragment Endotrophin in Cancer. Onco Targets Ther 2020;13:5779-93. [PMID: 32606789 DOI: 10.2147/OTT.S256654] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
48 Jung SH, Kim HJ, Oh GS, Shen A, Lee S, Choe SK, Park R, So HS. Capsaicin ameliorates cisplatin-induced renal injury through induction of heme oxygenase-1. Mol Cells 2014;37:234-40. [PMID: 24642709 DOI: 10.14348/molcells.2014.2322] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
49 Liu M, Jia Z, Sun Y, Zhang A, Yang T. A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice. Mediators Inflamm 2016;2016:8145785. [PMID: 27340345 DOI: 10.1155/2016/8145785] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
50 Zafari J, Zadehmodarres S, Javani Jouni F, Bagheri-Hosseinabadi Z, Najjar N, Asnaashari M. Investigation into the Effect of Photodynamic Therapy and Cisplatin on the Cervical Cancer Cell Line (A2780). J Lasers Med Sci 2020;11:S85-91. [PMID: 33995975 DOI: 10.34172/jlms.2020.S14] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Krizkova S, Fabrik I, Huska D, Adam V, Babula P, Hrabeta J, Eckschlager T, Pochop P, Darsova D, Kukacka J, Prusa R, Trnkova L, Kizek R. An adsorptive transfer technique coupled with brdicka reaction to reveal the importance of metallothionein in chemotherapy with platinum based cytostatics. Int J Mol Sci 2010;11:4826-42. [PMID: 21614176 DOI: 10.3390/ijms11124826] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
52 Zhang J, Lin M, Jin Y, Gu L, Li T, Yuan B, Wang B, Wang L, Zhang S, Cao J, Tao Z, Zhang J, Hu X. Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia. Breast Cancer Res Treat 2020;182:719-26. [PMID: 32524355 DOI: 10.1007/s10549-020-05730-2] [Reference Citation Analysis]
53 Ma Y, Yu WD, Hershberger PA, Flynn G, Kong RX, Trump DL, Johnson CS. 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Mol Cancer Ther 2008;7:3047-55. [PMID: 18790784 DOI: 10.1158/1535-7163.MCT-08-0243] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
54 Wangpaichitr M, Theodoropoulos G, Nguyen DJM, Wu C, Spector SA, Feun LG, Savaraj N. Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration. Int J Mol Sci 2021;22:7379. [PMID: 34298999 DOI: 10.3390/ijms22147379] [Reference Citation Analysis]
55 Scalabrin M, Dixit SM, Makshood MM, Krzemien CE, Fabris D. Bifunctional cross-linking approaches for mass spectrometry-based investigation of nucleic acids and protein-nucleic acid assemblies. Methods 2018;144:64-78. [PMID: 29753003 DOI: 10.1016/j.ymeth.2018.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Stehlikova K, Kostrhunova H, Kasparkova J, Brabec V. DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent. Nucleic Acids Res 2002;30:2894-8. [PMID: 12087174 DOI: 10.1093/nar/gkf405] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.4] [Reference Citation Analysis]
57 Grimaldi M, Santin G, Insolia V, Dal Bo V, Piccolini VM, Veneroni P, Barni S, Verri M, De Pascali SA, Fanizzi FP, Bernocchi G, Bottone MG. [Pt(O,O'-acac)(γ-acac)(DMS)] versus cisplatin: apoptotic effects in B50 neuroblastoma cells. Histochem Cell Biol 2016;145:587-601. [PMID: 26748644 DOI: 10.1007/s00418-015-1396-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
58 Pabla N, Dong Z. Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment. Oncotarget 2012;3:107-11. [PMID: 22403741 DOI: 10.18632/oncotarget.439] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
59 Ribeiro-Silva C, Aydin ÖZ, Mesquita-Ribeiro R, Slyskova J, Helfricht A, Marteijn JA, Hoeijmakers JHJ, Lans H, Vermeulen W. DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1. Nat Commun 2018;9:4067. [PMID: 30287812 DOI: 10.1038/s41467-018-06402-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
60 Maghsoudi O, Mirjalili SH, Dolatabadi M, Joshaghani MF, Zarea M, Yahaghi E, Mokarizadeh A. Investigations of renal function using the level of neutrophil gelatinase-associated lipocalin associated with single-dose of cisplatin during chemotherapy. Diagn Pathol 2015;10:98. [PMID: 26170013 DOI: 10.1186/s13000-015-0338-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Höhn A, Krüger K, Skowron MA, Bormann S, Schumacher L, Schulz WA, Hoffmann MJ, Niegisch G, Fritz G. Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells. Oncotarget 2016;7:41320-35. [PMID: 27191498 DOI: 10.18632/oncotarget.9321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
62 Miodragović Đ, Merlino A, Swindell EP, Bogachkov A, Ahn RW, Abuhadba S, Ferraro G, Marzo T, Mazar AP, Messori L, O'Halloran TV. Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent. J Am Chem Soc 2019;141:6453-7. [PMID: 30943017 DOI: 10.1021/jacs.8b13681] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
63 Ratzon E, Najajreh Y, Salem R, Khamaisie H, Ruthardt M, Mahajna J. Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study. BMC Cancer 2016;16:140. [PMID: 26906901 DOI: 10.1186/s12885-016-2182-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
64 Intini FP, Boccarelli A, Francia VC, Pacifico C, Sivo MF, Natile G, Giordano D, De Rinaldis P, Coluccia M. Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties. J Biol Inorg Chem 2004;9:768-80. [PMID: 15241660 DOI: 10.1007/s00775-004-0572-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
65 Almassalha LM, Bauer GM, Chandler JE, Gladstein S, Cherkezyan L, Stypula-Cyrus Y, Weinberg S, Zhang D, Thusgaard Ruhoff P, Roy HK, Subramanian H, Chandel NS, Szleifer I, Backman V. Label-free imaging of the native, living cellular nanoarchitecture using partial-wave spectroscopic microscopy. Proc Natl Acad Sci U S A 2016;113:E6372-81. [PMID: 27702891 DOI: 10.1073/pnas.1608198113] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 7.6] [Reference Citation Analysis]
66 Sharifan A, Etebari M, Zolfaghari B, Aliomrani M. Investigating the effects of bark extract and volatile oil of Pinus eldarica against cisplatin-induced genotoxicity on HUVECs cell line. Toxicol Res (Camb) 2021;10:223-31. [PMID: 33884173 DOI: 10.1093/toxres/tfab006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
67 Zhao J, Xiang Y, Xiao C, Guo P, Wang D, Liu Y, Shen Y. AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells. Int J Med Sci 2014;11:1089-97. [PMID: 25170291 DOI: 10.7150/ijms.9239] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
68 Arora S, Heyza JR, Chalfin EC, Ruch RJ, Patrick SM. Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling. Cancers (Basel). 2018;10:pii: E368. [PMID: 30279363 DOI: 10.3390/cancers10100368] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
69 Yang Y, Fu Y, Wang P, Liu S, Sha Y, Zhang Y, Zhang A, Jia Z, Ding G, Huang S. Intervention of mitochondrial activity attenuates cisplatin-induced acute kidney injury. Int Urol Nephrol 2019;51:1207-18. [PMID: 31020626 DOI: 10.1007/s11255-019-02113-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
70 Berning L, Schlütermann D, Friedrich A, Berleth N, Sun Y, Wu W, Mendiburo MJ, Deitersen J, Brass HUC, Skowron MA, Hoffmann MJ, Niegisch G, Pietruszka J, Stork B. Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment. Molecules 2021;26:1294. [PMID: 33673611 DOI: 10.3390/molecules26051294] [Reference Citation Analysis]
71 Wong JH, Brown JA, Suo Z, Blum P, Nohmi T, Ling H. Structural insight into dynamic bypass of the major cisplatin-DNA adduct by Y-family polymerase Dpo4. EMBO J 2010;29:2059-69. [PMID: 20512114 DOI: 10.1038/emboj.2010.101] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
72 Wang Q, Zheng XL, Yang L, Shi F, Gao LB, Zhong YJ, Sun H, He F, Lin Y, Wang X. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J Exp Clin Cancer Res 2010;29:159. [PMID: 21143894 DOI: 10.1186/1756-9966-29-159] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.9] [Reference Citation Analysis]
73 Kim SY, Lee JR. Fertility preservation option in young women with ovarian cancer. Future Oncol 2016;12:1695-8. [PMID: 27193251 DOI: 10.2217/fon-2016-0181] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
74 Li Y, Tang T, Lee HJ, Song K. Selective Anti-Cancer Effects of Plasma-Activated Medium and Its High Efficacy with Cisplatin on Hepatocellular Carcinoma with Cancer Stem Cell Characteristics. Int J Mol Sci 2021;22:3956. [PMID: 33921230 DOI: 10.3390/ijms22083956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 赵洪礼, 韩莎, 李琳, 丁敬献, 杨景玉. ERCC1在食管癌顺铂化疗中的作用. 世界华人消化杂志 2013; 21(16): 1493-1497 [DOI: 10.11569/wcjd.v21.i16.1493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Kulkarni A, Wilson DM 3rd. The involvement of DNA-damage and -repair defects in neurological dysfunction. Am J Hum Genet 2008;82:539-66. [PMID: 18319069 DOI: 10.1016/j.ajhg.2008.01.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
77 Steinemann G, Dittmer A, Schmidt J, Josuttis D, Fähling M, Biersack B, Beindorff N, Jolante Koziolek E, Schobert R, Brenner W, Müller T, Nitzsche B, Höpfner M. Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer. Mol Oncol 2019;13:2679-96. [PMID: 31583820 DOI: 10.1002/1878-0261.12582] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
78 Dupre TV, Doll MA, Shah PP, Sharp CN, Siow D, Megyesi J, Shayman J, Bielawska A, Bielawski J, Beverly LJ, Hernandez-Corbacho M, Clarke CJ, Snider AJ, Schnellmann RG, Obeid LM, Hannun YA, Siskind LJ. Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury. J Lipid Res 2017;58:1439-52. [PMID: 28490444 DOI: 10.1194/jlr.M076745] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
79 Swenson MC, Paranawithana SR, Miller PS, Kielkopf CL. Structure of a DNA repair substrate containing an alkyl interstrand cross-link at 1.65 A resolution. Biochemistry 2007;46:4545-53. [PMID: 17375936 DOI: 10.1021/bi700109r] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
80 Suchánková T, Vojtísková M, Reedijk J, Brabec V, Kaspárková J. DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects. J Biol Inorg Chem 2009;14:75-87. [PMID: 18777181 DOI: 10.1007/s00775-008-0425-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
81 Nitiss JL. A copper connection to the uptake of platinum anticancer drugs. Proc Natl Acad Sci U S A 2002;99:13963-5. [PMID: 12391309 DOI: 10.1073/pnas.232574299] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
82 Wang QE, Milum K, Han C, Huang YW, Wani G, Thomale J, Wani AA. Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells. Mol Cancer 2011;10:24. [PMID: 21385444 DOI: 10.1186/1476-4598-10-24] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
83 Lin XM, Luo W, Wang H, Li RZ, Huang YS, Chen LK, Wu XP. The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer. Front Pharmacol 2019;10:836. [PMID: 31440159 DOI: 10.3389/fphar.2019.00836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
84 Sharma R, Knoll JD, Ancona N, Martin PD, Turro C, Kodanko JJ. Solid-phase synthesis as a platform for the discovery of new ruthenium complexes for efficient release of photocaged ligands with visible light. Inorg Chem 2015;54:1901-11. [PMID: 25611351 DOI: 10.1021/ic502791y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
85 Deng Z, Wang H, Guo G, Li X, Cai Y, Tang Y, Wang Y, Li J, Lu Z, Yu X, Li R, Li L. Next-Generation Sequencing Analysis of mRNA Profile in Cisplatin-Resistant Gastric Cancer Cell Line SGC7901. Med Sci Monit 2019;25:2386-96. [PMID: 30938333 DOI: 10.12659/MSM.915866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
86 Kothandapani A, Gopalakrishnan K, Kahali B, Reisman D, Patrick SM. Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Exp Cell Res 2012;318:1973-86. [PMID: 22721696 DOI: 10.1016/j.yexcr.2012.06.011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
87 Yu H, Guo C, Feng B, Liu J, Chen X, Wang D, Teng L, Li Y, Yin Q, Zhang Z, Li Y. Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer. Theranostics 2016;6:14-27. [PMID: 26722370 DOI: 10.7150/thno.13515] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 10.8] [Reference Citation Analysis]
88 Yürekli Y, Unak P, Yenisey C, Ertay T, Biber Müftüler FZ, Medine Eİ. L-Carnitine Protection Against Cisplatin Nephrotoxicity In Rats: Comparison with Amifostin Using Quantitative Renal Tc 99m DMSA Uptake. Mol Imaging Radionucl Ther 2011;20:1-6. [PMID: 23486728 DOI: 10.4274/MIRT.20.01] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
89 Melnikova M, Wauer US, Mendus D, Hilger RA, Oliver TG, Mercer K, Gohlke BO, Erdmann K, Niederacher D, Neubauer H, Buderath P, Wimberger P, Kuhlmann JD, Thomale J. Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells. Mol Oncol 2020;14:686-703. [PMID: 32037720 DOI: 10.1002/1878-0261.12648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Dickerson M, Sun Y, Howerton B, Glazer EC. Modifying charge and hydrophilicity of simple Ru(II) polypyridyl complexes radically alters biological activities: old complexes, surprising new tricks. Inorg Chem 2014;53:10370-7. [PMID: 25249443 DOI: 10.1021/ic5013796] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 10.1] [Reference Citation Analysis]
91 Zentout S, Smith R, Jacquier M, Huet S. New Methodologies to Study DNA Repair Processes in Space and Time Within Living Cells. Front Cell Dev Biol 2021;9:730998. [PMID: 34589495 DOI: 10.3389/fcell.2021.730998] [Reference Citation Analysis]
92 Frezza M, Dou QP, Xiao Y, Samouei H, Rashidi M, Samari F, Hemmateenejad B. In vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands. J Med Chem 2011;54:6166-76. [PMID: 21815643 DOI: 10.1021/jm2006832] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
93 Barakat BM, Wang QE, Han C, Milum K, Yin DT, Zhao Q, Wani G, Arafa el-SA, El-Mahdy MA, Wani AA. Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis. Int J Cancer 2010;127:977-88. [PMID: 20013802 DOI: 10.1002/ijc.25112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 34] [Article Influence: 0.6] [Reference Citation Analysis]
94 Xiao Y, Liang MR, Liu CC, Wang YN, Zeng Y, Zhou J, Zhu HT, Wang Q, Zou Y, Zeng SY. Overexpression of P16 reversed the MDR1-mediated DDP resistance in the cervical adenocarcinoma by activating the ERK1/2 signaling pathway. Cell Div 2019;14:6. [PMID: 31312250 DOI: 10.1186/s13008-019-0048-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
95 Chan H, Pearson CS, Green CM, Li Z, Zhang J, Belfort G, Shekhtman A, Li H, Belfort M. Exploring Intein Inhibition by Platinum Compounds as an Antimicrobial Strategy. J Biol Chem 2016;291:22661-70. [PMID: 27609519 DOI: 10.1074/jbc.M116.747824] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
96 Xu Y, Zhu S, Zhao H, Li Q. Identification and characterisation of lamprey protein kinase C delta-like gene. Sci Rep 2017;7:12214. [PMID: 28939820 DOI: 10.1038/s41598-017-12526-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
97 Fox JT, Sakamuru S, Huang R, Teneva N, Simmons SO, Xia M, Tice RR, Austin CP, Myung K. High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc Natl Acad Sci U S A 2012;109:5423-8. [PMID: 22431602 DOI: 10.1073/pnas.1114278109] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 8.8] [Reference Citation Analysis]
98 Khabele D. The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer. Front Oncol 2014;4:111. [PMID: 24904826 DOI: 10.3389/fonc.2014.00111] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
99 Hu XF, Li J, Vandervalk S, Wang Z, Magnuson NS, Xing PX. PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest. 2009;119:362-375. [PMID: 19147983 DOI: 10.1172/jci33216] [Cited by in Crossref: 4] [Cited by in F6Publishing: 43] [Article Influence: 0.3] [Reference Citation Analysis]
100 Liu YH, Li K, Tian HQ. Renoprotective Effects of a New Free Radical Scavenger, XH-003, against Cisplatin-Induced Nephrotoxicity. Oxid Med Cell Longev 2020;2020:9820168. [PMID: 32377314 DOI: 10.1155/2020/9820168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
101 Heidary DK, Fox A, Richards CI, Glazer EC. A High-Throughput Screening Assay Using a Photoconvertable Protein for Identifying Inhibitors of Transcription, Translation, or Proteasomal Degradation. SLAS Discov 2017;22:399-407. [PMID: 28328316 DOI: 10.1177/2472555216684333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
102 Cepero V, García-Serrelde B, Moneo V, Blanco F, González-Vadillo AM, Alvarez-Valdés A, Navarro-Ranninger C, Carnero A. Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription. Clin Transl Oncol 2007;9:521-30. [PMID: 17720655 DOI: 10.1007/s12094-007-0096-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
103 Dannen SD, Cornelison L, Durham P, Morley JE, Shahverdi K, Du J, Zhou H, Sudlow LC, Hunter D, Wood MD, Berezin MY, Gerasimchuk N. New in vitro highly cytotoxic platinum and palladium cyanoximates with minimal side effects in vivo. J Inorg Biochem 2020;208:111082. [PMID: 32413634 DOI: 10.1016/j.jinorgbio.2020.111082] [Reference Citation Analysis]
104 Koren Carmi Y, Mahmoud H, Khamaisi H, Adawi R, Gopas J, Mahajna J. Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion. Int J Mol Sci 2020;21:E6533. [PMID: 32906729 DOI: 10.3390/ijms21186533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
105 Ferraro G, Marzo T, Cucciolito ME, Ruffo F, Messori L, Merlino A. Reaction with Proteins of a Five-Coordinate Platinum(II) Compound. Int J Mol Sci 2019;20:E520. [PMID: 30691130 DOI: 10.3390/ijms20030520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
106 Galgamuwa R, Hardy K, Dahlstrom JE, Blackburn AC, Wium E, Rooke M, Cappello JY, Tummala P, Patel HR, Chuah A, Tian L, McMorrow L, Board PG, Theodoratos A. Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties. J Am Soc Nephrol 2016;27:3331-44. [PMID: 26961349 DOI: 10.1681/ASN.2015070827] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 6.4] [Reference Citation Analysis]
107 Jiang M, Liu Z, Xiang Y, Ma H, Liu S, Liu Y, Zheng D. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma. BMC Cancer 2011;11:54. [PMID: 21291526 DOI: 10.1186/1471-2407-11-54] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
108 Chválová K, Brabec V, Kaspárková J. Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin. Nucleic Acids Res 2007;35:1812-21. [PMID: 17329374 DOI: 10.1093/nar/gkm032] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 6.6] [Reference Citation Analysis]
109 Campbell MA, Miller PS. Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA. Bioconjug Chem 2009;20:2222-30. [PMID: 19950917 DOI: 10.1021/bc900008s] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
110 Anabtawi N, Cvammen W, Kemp MG. Pharmacological inhibition of cryptochrome and REV-ERB promotes DNA repair and cell cycle arrest in cisplatin-treated human cells. Sci Rep 2021;11:17997. [PMID: 34504274 DOI: 10.1038/s41598-021-97603-x] [Reference Citation Analysis]
111 Jeon J, Lee S, Kim H, Kang H, Youn H, Jo S, Youn B, Kim HY. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas. Int J Mol Sci 2021;22:5111. [PMID: 34065991 DOI: 10.3390/ijms22105111] [Reference Citation Analysis]
112 Bodo J, Hunakova L, Kvasnicka P, Jakubikova J, Duraj J, Kasparkova J, Sedlak J. Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations. Br J Cancer 2006;95:1348-53. [PMID: 17060935 DOI: 10.1038/sj.bjc.6603434] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
113 Chen DT, Chan W, Thompson ZJ, Thapa R, Beg AA, Saltos AN, Chiappori AA, Gray JE, Haura EB, Rose TA, Creelan B. Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer. PLoS One 2021;16:e0252041. [PMID: 34197475 DOI: 10.1371/journal.pone.0252041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Ayyagari VN, Hsieh TJ, Diaz-Sylvester PL, Brard L. Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines. BMC Cancer 2017;17:49. [PMID: 28086831 DOI: 10.1186/s12885-016-3034-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
115 Herrera-Pérez Z, Gretz N, Dweep H. A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity. Curr Genomics 2016;17:279-93. [PMID: 27252593 DOI: 10.2174/1389202917666160202220555] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
116 Cinellu MA, Maiore L, Manassero M, Casini A, Arca M, Fiebig HH, Kelter G, Michelucci E, Pieraccini G, Gabbiani C. [Au2(phen(2Me))2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties. ACS Med Chem Lett. 2010;1:336-339. [PMID: 24900215 DOI: 10.1021/ml100097f] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 6.6] [Reference Citation Analysis]
117 Srivastava AK, Han C, Zhao R, Cui T, Dai Y, Mao C, Zhao W, Zhang X, Yu J, Wang QE. Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells. Proc Natl Acad Sci U S A 2015;112:4411-6. [PMID: 25831546 DOI: 10.1073/pnas.1421365112] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 18.3] [Reference Citation Analysis]
118 Li F, Livingston MJ, Dong Z. Protection of kidneys by magnesium in cisplatin chemotherapy: a fight between two metals. Am J Physiol Renal Physiol 2017;313:F955-6. [PMID: 28637790 DOI: 10.1152/ajprenal.00294.2017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
119 Tanabe K, Tamura Y, Lanaspa MA, Miyazaki M, Suzuki N, Sato W, Maeshima Y, Schreiner GF, Villarreal FJ, Johnson RJ, Nakagawa T. Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy. Am J Physiol Renal Physiol 2012;303:F1264-74. [PMID: 22933302 DOI: 10.1152/ajprenal.00227.2012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
120 Lee TH, Park D, Kim YJ, Lee I, Kim S, Oh CT, Kim JY, Yang J, Jo SK. Lactobacillus salivarius BP121 prevents cisplatin‑induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p‑cresol sulfate via alleviating dysbiosis. Int J Mol Med 2020;45:1130-40. [PMID: 32124946 DOI: 10.3892/ijmm.2020.4495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]